Prevention of Adriamycin-Induced Drug-Resistance of Leukemia Cells by Α-Tocopheryl Succinate and Arsenic Trioxide

LIU Xiu-hua,WEI Hu-lai
DOI: https://doi.org/10.3969/j.issn.1000-2812.2006.02.006
2006-01-01
Abstract:Objective To observe the preventive effects of α-tocopheryl succinate(α-TOS) and arsenic trioxide on adriamycin-initiated drug-resistance of human leukemia K562 cells. Methods Human leukemia cell K562 was used as target cell, the cell was induced to produce resistance to ADM, simulating the procedure of chemotherapeutics, with the way of intermittent stimulation and gradually increasing the dosage of the drug, and simultaneous administration of α-TOS or As2O3 was employed to investigate its effects on the induction of drug-resistance. Drug-resistance was examined with MTT colorimetric assay, and cytomorphology was checked by light microscopy. Expression of P-glycoprotein(P-gp) was detected by immunofluorescence and flow cytometry. and the cellular ADM content was detected by fluorescence microscopy. Results After five months induction with ADM, the resistance of K562 cells to ADM was 5-fold higher than that of untreated K562 cells, and cross-resistant to daunorubicin. The P-gp expression and ADM content increased markedly in ADM-treated K562 cells. Combination with α-TOS or As2O3 could inhibit P-gp expression and increase cellular ADM content at different degrees, and reduce or delay the development of drug resistance in ADM-induced K562 cells. Conclusion α-TOS and As2O3 are able to reduce or delay ADM-induced resistance in leukemia K562 cells via down-regulation of P-gp expression.
What problem does this paper attempt to address?